Marina García Selected Research

Hantavirus Pulmonary Syndrome

1/2019	Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome.
1/2017	Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina García Research Topics

Disease

3	COVID-19 01/2021 - 01/2020
2	Infections 11/2020 - 01/2017
2	Hantavirus Pulmonary Syndrome 01/2019 - 01/2017
1	Heart Failure 06/2022
1	Convalescence 01/2022
1	Hantavirus Infections 01/2020
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Persistent Infection 11/2016
1	Celiac Disease (Celiac Sprue) 01/2015

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Neutralizing AntibodiesIBA 01/2022 - 11/2020
2	AntibodiesIBA 01/2021 - 01/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 06/2022
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 06/2022
1	DiureticsIBA 06/2022
1	Viral RNAIBA 01/2022
1	Immunoglobulin G (IgG)IBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	Nucleocapsid ProteinsIBA 11/2020
1	Immunoglobulin A (IgA)IBA 11/2020
1	Immunoglobulin M (IgM)IBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	StaurosporineIBA 01/2020
1	EnzymesIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	CytokinesIBA 01/2019
1	AntigensIBA 11/2016
1	Fatty Acid-Binding ProteinsIBA 01/2015
1	Glutens (Glutelin)IBA 01/2015

Therapy/Procedure

1	Therapeutics 06/2022